Meet the Researcher: Yubing Xia

My research focuses on HER2-positive breast cancer, a type of breast cancer that is treated with a targeted drug called trastuzumab before surgery. I am investigating how a patient’s immune system influences how well this treatment works. We believe that a patient’s overall “immune readiness” before treatment may help predict whether they will respond well. […]